Greek hospitals have drug supply stopped by Roche

By Admin
The pharmaceutical giant Roche has stopped delivering medications to some hospitals in Greece after they failed to settle outstanding bills with the co...

The pharmaceutical giant Roche has stopped delivering medications to some hospitals in Greece after they failed to settle outstanding bills with the company.

Roche’s CEO, Severin Schwan, reportedly told the Wall Street Journal (WSJ) newspaper some state-owned hospitals “haven’t paid their bills in three or four years.”

He added similar steps are being considered elsewhere, particularly in other European countries of Italy, Spain and Portugal where state-run hospitals are also late on bill payments.   

To read the latest edition of Healthcare Global, click here

In the WSJ report, Schwan said although Roche was not currently delivering to hospitals, it had increased its supply to local pharmacies and was adamant patients were not suffering as a result.

Schwan believes the pharmacies in Greece are much more reliable in terms of payments and said public hospitals “have the habit of not paying the pharmaceutical industry.”

He said: “There comes a point where the business is not sustainable anymore.”

In what appears to be an attempt to regain some credibility, the hospitals started to repay the bills after Roche cut off its supply.

According to Schwan, the hospitals “understood that their reputation vis a vis the patients was at risk” and are working to amend the situation.

The move by Roche comes after Danish company Novo Nordisk A/S refused to deliver insulin to Greece after it revealed it was planning to reduce its price by up to 50 percent.

The situation is the result of Greece’s poor economic climate, which has seen budget cuts heavily imposed across the country. It is thought state-run hospitals in Greece are in huge amounts of debt to a number of drug companies.

The Hellenic Association of Pharmaceutical Companies believes out of the €1.9 billion worth of drugs delivered to public hospitals in Greece within the past 18 months, only 37 percent of the amount has been paid back. 

Our magazine is now available on the iPad. Click here to download it.

Share

Featured Articles

Snowflake: Transforming patient healthcare with Gen AI

Jesse Cugliotta, Healthcare & Life Science at Snowflake, discusses revolutionising healthcare efficiency and improving patient care with Gen AI

Johnson & Johnson: Turning supplier spend into local support

Johnson & Johnson’s Global Supplier Diversity & Inclusion team is growing spending with social enterprises around the globe to expand its impact

Seasonal Affective Disorder’s impact on health & solutions

Dr Ravi Gill & Dr. Naomi Newman-Beinart discuss Seasonal Affective Disorder and its treatments, from vitamin D spray to light therapy

CGI teams up with Totalmobile for digital healthcare service

Digital Healthcare

Deloitte: generative AI can improve access to healthcare

Technology & AI

Wipro & NVIDIA’s revolutionary healthcare uses generative AI

AI & ML